| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.45 | 7e-17 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-10 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |